The cornerstone of CD diagnosis relies on tissue transglutaminase immunoglobulin (Ig) A (TGA-IgA) testing, typically accompanied by total IgA measurement to identify selective IgA deficiency (sIgAD). Here, CD79A is linked to selective IgA deficiency disease.